Subscribe to Christianity Today
Subscribe to Christianity Today
July 24, 2008
Free E-mail Newsletters:
RSS Feed | More Feeds | RSS Help

Home > 2001 > October 1Christianity Today, October 1, 2001  |   |  
A Matter of Life and Death
Why shouldn't we use our embryos and genes to make our lives better? The world awaits a Christian answer



ADVERTISEMENT
On June 26, 2000, scientists Francis Collins and J. Craig Venter joined Bill Clinton at the White House for the stunning announcement that researchers had mapped 90 percent of the genes on the human genome, which contains codes for all inherited characteristics. The President declared, "Today, we are learning the language in which God created life."

Humanity will spend much of the 21st century attempting to speak that language. A fast-developing biotech vocabulary—genetic therapy, stem cells, reproductive cloning, and so on—strains the ability of even the most thoughtful to keep up. Human life may soon be changed dramatically, and Christians must participate in the international conversation about these changes before they become irreversible.

The Christian faith has the potential to serve not just the church but the world by penetrating the fog of current events to discern their deeper meaning—and to offer clear-headed analysis amid growing confusion.

Opposing Forces

Long-established forces threaten to crowd out the voice of faith:

Market forces. The sprawling biotech industry, already doing $80 billion in business in the United States alone, would not be awash in money were there not a demand for its innovations. These products and services include stem cells, gene therapies and enhancements, and, one day, perhaps soon, clones. Biotech firms promise what people want—health, pain relief, reproduction, longevity, success.

Thus far they do so with little public regulation or control, one of the most troubling features of our new era—unlike the nuclear weapons challenge posed last century, harrowing as that was. Then government policy threatened humanity; today, corporate interests do.

Moral fragmentation. A morally fragmented nation may lack the basic requisites for a conversation—a shared framework of meaning, a minimal level of trust, and an agreed-upon vocabulary. But by failing to converse and arrive at a national (much less international) decision about the biotech revolution, we default to existing powers and interests and likely stumble into disaster.

"Our society currently lives from moral fragments and community fragments only, both of which are being destroyed faster than they are being replenished," writes ethicist Larry L. Rasmussen.

Worldview dynamics. This leads us to a still deeper reality: beneath both economic practice and moral fragmentation lies the foundation of worldview. Among those who press most aggressively for unrestrained development of biotech advances —including nonscientists—worldviews and philosophies such as naturalism, atheism, utilitarianism, and scientific utopianism reign. Much of our culture's élite lives without a working hypothesis of God. Assuming we dwell alone in the universe, they believe we must simply keep improving life until the next comet hits.

Libertarian ideology—which stresses individualism, privacy, moral relativism, unlimited choice-making, and autonomy—folds neatly into these godless worldviews. It holds that no one should deny himself anything that will bring self-realization and is not immediately harmful to another.

Hence a powerful contingent argues for the largely unrestrained pursuit of biotechnology as a matter of personal (including reproductive) liberty. This quest is driven by a utopian dream: overcoming our species' limits through human power and scientific progress.

Some suggest triumphantly that our species is about to evolve right past homo sapiens to what New Republic senior editor Gregg Easterbrook calls homo geneticus. One enthusiast has said that future generations will look back on our time as "the point in history when human beings gained the power to seize control of their own evolutionary destiny."





E-mail this pageWrite CTPrint this articlePost a comment





  


Subscribe to Christianity Today and get 3 free trial issues. No credit card required.

Please allow 4-6 weeks for delivery. Offer valid in U.S. only.

If you decide you want to keep Christianity Today coming, honor your invoice for just $19.95 and receive nine more issues, a full year in all. If not, simply write "cancel" across the invoice and return it. The three trial issues are yours to keep, regardless.


Click here for international orders2-for-1 Gifts!

[Reader Reviews]
Average User Rating: Not rated

sponsors 








[Browse More Christianity Today]

Search





















Search by Name
Or use Advanced Search to search by program, region, cost, affiliation, enrollment, more!

Search by:





Books & Culture
Christianity Today
Church Law & Tax Report
Church Finance Today
Church Secretary Today
Ignite Your Faith
Leadership Journal
Men of Integrity
Outcomes
Today's Christian
Today's Christian Woman
Your Church
ChristianityTodayLibrary.com
PreachingToday.com